Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian CancerAdam D. Steg(University of Alabama at Birmingham), Charles N. Landen(University of Alabama at Birmingham)Clinical Cancer ResearchDecember 6, 201110.1158/1078-0432.ccr-11-2188Cited by 368SaveCiteExport RISWatch citationsRelated PapersUsing heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer|Oncotarget|2014|119